الولايات المتحدة · منصات وبيانات · Yahoo Finance

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

نشره Yahoo Finance · الولايات المتحدة منذ 9 س

Mr. Astley-Sparke brings more than two decades of biotech leadership, having scaled several highly innovative transatlantic companies, including Replimune, uniQure and BioVex --…

اقرأ المقال كاملًا على Yahoo Finance سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (finance.yahoo.com)

يستحق القراءة أيضًا

MarketBeat

SunCoke Energy (SXC) Set to Post Quarterly Earnings on Tuesday

The Motley Fool

Not Palantir. Not Snowflake. This AI Software Stock Could Be the Biggest Winner of 2027.

MarketWatch

‘I don’t feel sorry for myself’: I’m 64 and will be renting for the rest of my life — but here’s I’m still hopeful

Seeking Alpha

Maersk, Hateco sign deal for $3.5B rail terminal network in northern Vietnam

Investing.com

Goldman lifts UK housebuilder volume forecasts; upgrades Taylor Wimpey

CNBC